Higher prevalence of dupilumab‐induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis
Sign Up to like & getrecommendations! Published in 2024 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12386
Abstract: Abstract Background Dupilumab has been shown to be an effective treatment in moderate‐to‐severe atopic dermatitis (AD) and severe asthma (SA). However, comparative real‐world analyses of adverse events (AE), particularly dupilumab‐associated ocular surface disease (DAOSD), are… read more here.
Keywords: adverse events; daily practice; ocular aes; prevalence ... See more keywords